The state Board of Pharmacy sought to limit access to a powerful antioxidant. When firefighters and their allies — including those from Sonoma County — pushed back, state regulators blinked.

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.

Opinion: Moore & Van Allen attorneys Tanisha Palvia and Darby Festa say the Trump administration DOJ is casting a wide net as ...

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

Health and wellness investment holding company Ascendis Health increased its net asset value (NAV) by 12% year-on-year to R660-million for the six months ended December 31. The higher NAV was driven ...

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy took a hit due to rising competition from off-brand, or ...

With a fragile ceasefire in place, medics look to repair hospitals and care centres to get services running again ...

Revisiting lenient crime laws, and reinstating meaningful penalties for retail theft to empower law enforcement to confront ...

Several important events have taken place on March 27. The US Food and Drug Administration approved Pfizer’s Viagra as the ...

With consumers spending significantly more time researching health-related content – up 20.9 percent in the Ipsos Iris digital audience data for January Those marketing health products must ensure ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...